MSU
VSEEW

Mizuho Securities USA’s VSee Health Warrant VSEEW Stock Holding History

Mizuho Securities USA’s Portfolio VSEEW Stock Details VSEEW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-67,740
Closed -$24K – 223
2021
Q4 		$24K Buy
+67,740
New +$26.4K ﹤0.01% 179

Other funds holding VSEEW

MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Mizuho Securities USA's VSEEW Position: Q1 2022 in Review

Mizuho Securities USA sold out of VSee Health Warrant (VSEEW) in Q1 2022, closing a stake of 67,740 shares — an estimated $24K sold.

Mizuho Securities USA first reported a position in VSEEW in Q4 2021 and held it in 1 quarter. The position peaked at $24K in Q4 2021. 29 funds tracked by Wall St. Rank hold VSEEW as of Q1 2022.

  • Mizuho Securities USA reported no remaining VSee Health Warrant position as of Q1 2022 after selling out during the quarter.
  • Mizuho Securities USA sold 67,740 VSee Health Warrant shares in Q1 2022, an estimated $24K.
  • Mizuho Securities USA first reported a position in VSee Health Warrant in Q4 2021 and held it in 1 quarter.
  • Mizuho Securities USA's VSee Health Warrant position peaked at $24K in Q4 2021.
  • 29 funds tracked by Wall St. Rank held VSee Health Warrant as of Q1 2022.

Based on Mizuho Securities USA's 13F filing for Q1 2022, filed 27 Apr 2022.